Evidence map›Paper›PMID 35129301›Full record

ArticleJournal of the International AIDS Society2022

HIV disclosure and depressive symptoms among pregnant women living with HIV: a cross-sectional study in the Democratic Republic of Congo.

Natalia Zotova, Itziar Familiar, Bienvenu Kawende, Fidele Lumande Kasindi, Noro Ravelomanana, Angela M Parcesepe, Adebola Adedimeji, Kathryn E Lancaster, Didine Kaba, Pélagie Babakazo and 1 more

Registry-linked trialAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03048669 (Continuous Quality Improvement Interventions to Improve Long Term Outcomes of Antiretroviral Therapy in Women Initiated on Therapy During Pregnancy or Breastfeeding in the Democratic Republic of Congo), which is not on this map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03048669 nacompletednot on this map

Continuous Quality Improvement Interventions to Improve Long Term Outcomes of Antiretroviral Therapy in Women Initiated on Therapy During Pregnancy or Breastfeeding in the Democratic Republic of Congo

TypeinterventionalSponsorAlbert Einstein College of MedicineRan2016 to 2022Enrolled5,053ConditionsHIV/AIDS, Antiretroviral Therapy, Pregnancy Outcomes, HIV-exposed InfantsArmsContinuous quality improvement
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Observational
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Natalia ZotovaDivision of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.ORCID 0000-0001-5396-8304
Itziar FamiliarDepartment of Psychiatry, Michigan State University, East Lansing, Michigan, USA.
Bienvenu KawendeSchool of Public Health, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Fidele Lumande KasindiSchool of Public Health, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Noro RavelomananaSchool of Public Health, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Angela M ParcesepeDepartment of Maternal and Child Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID 0000-0002-4321-125X
Adebola AdedimejiDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, USA.
Kathryn E LancasterDivision of Epidemiology, College of Public Health, Ohio State University, Columbus, Ohio, USA.ORCID 0000-0003-2389-6973
Didine KabaSchool of Public Health, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Pélagie BabakazoSchool of Public Health, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Marcel YotebiengDivision of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.

Funding

"Enhancing Cancer Research in Central Africa IeDEA"U01AI096299 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Denis Nash, Marcel Yotebieng · 2011 to 2026
$35.8M
Einstein/Rwanda/DRC Consortium for Research in HIV/HPV/MalignanciesU54CA254568 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI YOTEBIENG, MARCEL · 2020 to 2024
$5.1M
HIV/ART, low birth weight, and mortality in HIV-exposed uninfected children: a translational mechanistic studyR01HD105526 · NICHD · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI KWIEK, JESSE J, YOTEBIENG, MARCEL · 2021 to 2025
$3.6M
Long term outcomes of therapy in women initiated on lifelong ART because of pregnancy in DR CongoR01HD087993 · NICHD · OHIO STATE UNIVERSITY · PI BABAKAZO, PELAGIE DIAMBALULA, YOTEBIENG, MARCEL · 2016 to 2020
$3.1M
NCI NIH HHS U54 CA254568NIAID NIH HHS U01 AI096299NICHD NIH HHS 1R01H087993NICHD NIH HHS R01 HD087993NICHD NIH HHS R01 HD105526NIH HHS NIAID U01AI096299NIH HHS NIHCD 1R01HD105526PEPFAR
6 · The paper itself

Abstract

introductionDisclosure of one's HIV status may decrease depression and improve the quality of life among people living with HIV. However, there is mixed evidence on the impact of disclosure to partners for pregnant women living with HIV (WLHIV) in areas of intersecting social concerns over disclosure and high prevalence of intimate partner violence (IPV). We assessed the association between HIV disclosure and depressive symptoms among pregnant WLHIV in the Democratic Republic of Congo (DRC) and examined whether the knowledge of partner's status or recent IPV modified this association.

methodsWe utilized data from participants enrolled in a trial to evaluate the effect of continuous quality interventions on long-term therapy outcomes among HIV-positive pregnant and breastfeeding women in DRC (NCT03048669). Only pregnant women (n = 1392) were included in this cross-sectional analysis. Between November 2016 and June 2019, enrolled participants completed a survey that included the Patient Health Questionnaire-9 (PHQ-9) to screen recent depressive symptoms, questions about disclosure, knowledge of partner's status and IPV. We used linear models to calculate crude and adjusted mean differences (MDs) between disclosure and depressive symptoms. All analyses were stratified by timing of HIV diagnosis.

resultsDisclosure was higher among participants diagnosed prior to current pregnancy (41% to their partners and 24% to family, friends or others) relative to those diagnosed during current pregnancy (21% to partners and 12% to family). About one-quarter of women reported any type of IPV in the past 12 months. Disclosure to a partner was associated with lower depressive symptoms among women diagnosed prior to current pregnancy (MD -0.55; 95% CI: -1.06, -0.04) but the opposite was observed among those diagnosed during current pregnancy (MD 0.5; 95% CI: -0.4, 1.4). Adjustment for IPV, knowledge of partner's status, age, number of living children and primigravidae did not change MDs substantially.

conclusionsWomen in our sample mostly disclosed to partners despite high IPV burden. The observed association between disclosure to partners and lower depressive symptoms among women diagnosed prior to current pregnancy is consistent with cross-national evidence. A prospective study among pregnant WLHIV is needed to examine longitudinal effects of HIV status disclosure.

Indexed as

HIV InfectionsIntimate Partner ViolenceChildCross-Sectional StudiesDemocratic Republic of the CongoDepressionDisclosureFemaleHumansPregnancyPregnant PeopleProspective StudiesQuality of LifeSexual PartnersdepressionDR CongoHIVintimate partner violencepregnant womenstatus disclosure

Identifiers

PMID35129301
PMCPMC8819634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.